Tuesday, April 26

COVID-19: Press Briefing by Press Secretary Jen Psaki and White House COVID-19 Response Coordinator Dr. Ashish Jha

COVID-19: Biden Administration Fact Sheet on Increased Access to COVID-19 Treatments and Boosting Patient and Provider Awareness

Nominees: President Biden Announces Key Regional Appointments for HHS

  • Ala Stanford, HHS Regional Director, Region 3
  • Antrell Tyson, HHS Regional Director, Region 4
  • Janine Boyd, HHS Regional Director, Region 5

Wednesday, April 27

COVID-19: Biden Administration Fact Sheet Underscoring Urgent Need for Additional COVID-19 Response Funding and the Severe Consequences of Congressional Inaction


Wednesday, April 26

FDA: HELP Committee Holds Hearing with FDA on User Fee Agreements

Thursday, April 27

Budget: House Energy and Commerce Committee Chairman Pallone Opening Remarks at Hearing on Proposed FY 2023 HHS Budget with Secretary Becerra

Veterans’ Health: House VA Committee Chairman Takano Introduces Remove Copays Act

Friday, April 28

Budget: House Ways and Means Committee Chairman Neal Opening Statement at Hearing on Proposed FY 2023 HHS Budget with Secretary Becerra

Public Health: Chairman Pallone of House Energy and Commerce Committee Applauds FDA Proposal to Ban Menthol-Flavored Cigarettes and Flavored Cigars


Thursday, April 27

HHS: HHS Issues Report Regarding Denials of Prior Authorization Requests by Some Medicare Advantage Organizations

Thursday, April 28

HHS: HHS Notice of Benefit and Payment Parameters for 2023 Final Rule (CMS-9911-F)

Friday, April 29

CMS: CMS Issues CY 2023 Medicare Advantage and Part D Final Rule (CMS-4192-F)


U.S. Senate Committee on Appropriations

Review Hearing on the President’s FY 2023 Funding Request and Budget Justification for HHS with Secretary Becerra

May 4, 2022 9:30 AM

U.S. Senate Committee on Veterans Affairs

Business Meeting on the Nomination of Shereef M. Elnahal, MD, to be Under Secretary for Health, Department of Veterans Affairs

Time TBD

U.S. Senate Committee on Commerce, Science

Hearing on Ensuring Fairness and Transparency in the Market for Prescription Drugs

May 5, 2022 10:00 AM


Leave a Reply